D.J. St. Germain’s Bio-Rad Laboratories Class A BIO Stock Holding History

D.J. St. Germain’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$1.11K	–	921
2026 Q1	$1.11K	Hold	4	–	–	﹤0.01%	843
2025 Q4	$1.21K	Hold	4	–	–	﹤0.01%	836
2025 Q3	$1.12K	Hold	4	–	–	﹤0.01%	825
2025 Q2	$965	Hold	4	–	–	﹤0.01%	819
2025 Q1	$974	Hold	4	–	–	﹤0.01%	759
2024 Q4	$1.31K	Hold	4	–	–	﹤0.01%	755
2024 Q3	$1.34K	Sell	4 -14	-78%	-$4.45K	﹤0.01%	697
2024 Q2	$4.92K	Buy	18 +14	+350%	+$4.07K	﹤0.01%	614
2024 Q1	$1.38K	Hold	4	–	–	﹤0.01%	706
2023 Q4	$1.29K	Hold	4	–	–	﹤0.01%	711
2023 Q3	$1.43K	Buy	+4	New	+$1.54K	﹤0.01%	679

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

D.J. St. Germain's BIO Position: Q2 2026 in Review

D.J. St. Germain sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 4 shares — an estimated $1.11K sold.

D.J. St. Germain first reported a position in BIO in Q3 2023 and held it in 11 quarters. The position peaked at $4.92K in Q2 2024. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

D.J. St. Germain reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
D.J. St. Germain sold 4 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.11K.
D.J. St. Germain first reported a position in Bio-Rad Laboratories Class A in Q3 2023 and held it in 11 quarters.
D.J. St. Germain's Bio-Rad Laboratories Class A position peaked at $4.92K in Q2 2024.
397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.